Maravai Lifesciences Holdings Inc Cl A (MRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 79,025 | 204,713 | 191,263 | 242,732 | 244,293 |
| Cost of Goods | 33,676 | 53,253 | 38,176 | 37,496 | 40,032 |
| Gross Profit | 45,349 | 151,460 | 153,087 | 205,236 | 204,261 |
| Operating Expenses | 43,492 | 42,467 | 36,360 | 25,031 | 36,927 |
| Operating Income | 2,533 | 109,246 | 116,903 | 180,701 | 167,366 |
| Interest Expense | 11,833 | 10,180 | 3,136 | 4,434 | 2,664 |
| Other Income | 4,777 | -3,190 | -4 | -1,275 | 2,139 |
| Pre-tax Income | -4,523 | 95,876 | 113,763 | 174,992 | 166,841 |
| Income Tax | -3,175 | 8,447 | 14,110 | 18,271 | 19,981 |
| Net Income Continuous | -1,348 | 87,429 | 99,653 | 156,721 | 146,860 |
| Minority Interests | -1,281 | 49,795 | 55,184 | 85,481 | 79,998 |
| Net Income | $-67 | $37,634 | $44,469 | $71,240 | $66,862 |
| EPS Basic Total Ops | 0.00 | 0.28 | 0.34 | 0.54 | 0.51 |
| EPS Basic Continuous Ops | -0.01 | 0.66 | 0.76 | 1.19 | 1.12 |
| EPS Diluted Total Ops | 0.00 | 0.30 | 0.34 | 0.53 | 0.50 |
| EPS Diluted Continuous Ops | -0.01 | -0.02 | 0.76 | 0.61 | 0.58 |
| EBITDA(a) | $14,159 | $119,929 | $127,536 | $190,321 | $177,321 |